Literature DB >> 23814729

The clinicopathologic manifestations of Plasmodium vivax malaria in children: a growing menace.

Prasun Bhattacharjee1, Suparna Dubey, Vijay Kumar Gupta, Prerana Agarwal, Mathura Prasad Mahato.   

Abstract

CONTEXT: Today, India faces increasing morbidity and mortality due to malaria, which is a global health burden. Plasmodium vivax which was once considered to have a benign course, is now being increasingly associated with complicated malaria. Studies which have been done on the increasing virulence of P. Vivax in children, are exceptionally rare. AIMS: This study has addressed some of the hitherto unanswered questions, such as: This study has tried to explore the wide spectrum of severe illnesses which are associated with P.vivax malaria in children.Other co-morbid conditions, which include a co-infection with P.falciparum, have been excluded with great care, to assess the increased virulence of P. Vivax.The present study was focused on the paediatric population with a large sample size of 168 subjects. SETTINGS AND
DESIGN: This was an observational retrospective analysis on the clinicopathologic manifestations of the paediatric cases which were admitted with severe malaria due to a mono-infection with Plasmodium vivax, in a tertiary-care centre in the national capital region, India. METHODS AND MATERIAL: The diagnosis of the mono-infection with P. Vivax malaria was established by making peripheral blood films (PBFs) and by doing rapid diagnostic tests. The severe forms of malaria were categorized as per the World Health Organization guidelines and the clinical and laboratory findings in these cases of complicated malaria were studied. STATISTICS: A descriptive statistical analysis was done by using the SPSS software and an Excel worksheet.
RESULTS: This comprehensive study revealed a multisystem involvement. Abdominal manifestations were observed in 75(45.8%) cases (which included hepatosplenomegaly, hepatomegaly, splenomegaly and ascites) and hepatic dysfunction and jaundice were observed in 28(16.7%) cases. The haematological tests showed moderate to severe anaemia in 151(89.9%) cases and thrombocytopaenia in 138(82.1%) cases. Petechiae were noted in 45(26.8%) cases and a gross bleeding was noted in 9(5.3%) cases. The respiratory findings which included tachypnoea, pleural effusions and ARDS were observed in 22(13.1%) cases. Renal dysfunction was noted clinically in 20(11.9%) cases and biochemically in 16(9.5%) cases. Shock was observed in 7(4.1%) cases, cerebral malaria was observed in 10(5.9%) cases and hypoglycaemia was observed in 5(3%) cases. Multi-organ dysfunction was detected in 11(6.54%) cases. The complications were more severe in the younger children (0-5 years).
CONCLUSIONS: A mono-infection with P. Vivax may lead to severe malaria and this increased virulence has resulted in the changing picture of P. Vivax malaria, leading to a spectrum of complications which are similar to those which are traditionally associated with P. Falciparum.

Entities:  

Keywords:  Complicated malaria; Plasmodium vivax; Severe malaria

Year:  2013        PMID: 23814729      PMCID: PMC3681056          DOI: 10.7860/JCDR/2013/5652.2960

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  17 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  The epidemiology of patients with severe malaria who died at the Hospital for Tropical Diseases, 1991-2004.

Authors:  Suparp Vannaphan; Tosaporn Saengnetswang; Plengsakoon Suwanakut; Auraiwon Kllangbuakong; Warin Klinnak; Piyathida Rungmatcha; Chaweewan Yeamput; Wipa Tanachartwet; Srivicha Krudsood; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2005-03       Impact factor: 0.267

3.  Severe thrombocytopenia suggesting immunological mechanisms in two cases of vivax malaria.

Authors:  S Yamaguchi; T Kubota; T Yamagishi; K Okamoto; T Izumi; M Takada; S Kanou; M Suzuki; J Tsuchiya; T Naruse
Journal:  Am J Hematol       Date:  1997-11       Impact factor: 10.047

4.  Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand.

Authors:  Saurabh Srivastava; Sohaib Ahmad; Nadia Shirazi; Sanjiv Kumar Verma; Prashant Puri
Journal:  Acta Trop       Date:  2010-10-11       Impact factor: 3.112

5.  Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua.

Authors:  Mazie J Barcus; Hasan Basri; Helena Picarima; C Manyakori; Iqbal Elyazar; Michael J Bangs; Jason D Maguire; J Kevin Baird
Journal:  Am J Trop Med Hyg       Date:  2007-11       Impact factor: 2.345

6.  Thrombocytopenia in malaria.

Authors:  S Looareesuwan; J G Davis; D L Allen; S H Lee; D Bunnag; N J White
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992-03       Impact factor: 0.267

Review 7.  Vivax malaria: neglected and not benign.

Authors:  Ric N Price; Emiliana Tjitra; Carlos A Guerra; Shunmay Yeung; Nicholas J White; Nicholas M Anstey
Journal:  Am J Trop Med Hyg       Date:  2007-12       Impact factor: 2.345

Review 8.  Renal failure in malaria.

Authors:  B S Das
Journal:  J Vector Borne Dis       Date:  2008-06       Impact factor: 1.688

9.  P. vivax malaria complicated by shock and ARDS.

Authors:  Sathish Kumar; Mark Melzer; Paul Dodds; Julie Watson; Rosalynn Ord
Journal:  Scand J Infect Dis       Date:  2007

10.  Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India.

Authors:  Dhanpat K Kochar; Ashish Das; Sanjay K Kochar; Vishal Saxena; Parmendra Sirohi; Shilpi Garg; Abhishek Kochar; Mahesh P Khatri; Vikas Gupta
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

View more
  7 in total

1.  Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin.

Authors:  Tasanee Panichakul; Saranyoo Ponnikorn; Sittiruk Roytrakul; Atchara Paemanee; Suthathip Kittisenachai; Suradej Hongeng; Rachanee Udomsangpetch
Journal:  Malar J       Date:  2015-03-31       Impact factor: 2.979

Review 2.  Respiratory Complications of Plasmodium vivax Malaria: Systematic Review and Meta-Analysis.

Authors:  Fernando Val; Kim Machado; Lisiane Barbosa; Jorge Luis Salinas; André Machado Siqueira; Maria Graças Costa Alecrim; Hernando Del Portillo; Quique Bassat; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

3.  Malaria and acute kidney injury.

Authors:  Denver D Brown; Sonia Solomon; Daniele Lerner; Marcela Del Rio
Journal:  Pediatr Nephrol       Date:  2019-01-31       Impact factor: 3.714

4.  Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier.

Authors:  Adéla Nacer; Alexandru Movila; Fabien Sohet; Natasha M Girgis; Uma Mahesh Gundra; P'ng Loke; Richard Daneman; Ute Frevert
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

5.  Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.

Authors:  Rachael Milligan; André Daher; Patricia M Graves
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

6.  Prevalence and risk factors related to poor outcome of patients with severe Plasmodium vivax infection: a systematic review, meta-analysis, and analysis of case reports.

Authors:  Manas Kotepui; Kwuntida Uthaisar Kotepui; Giovanni De Jesus Milanez; Frederick Ramirez Masangkay
Journal:  BMC Infect Dis       Date:  2020-05-24       Impact factor: 3.090

7.  Vivax malaria in an Amazonian child with dilated cardiomyopathy.

Authors:  Antonio C Martins; Jamille B Lins; Luana M N Santos; Licia N Fernandes; Rosely S Malafronte; Teresa C Maia; Melissa C V Ribera; Ricardo B Ribera; Monica da Silva-Nunes
Journal:  Malar J       Date:  2014-02-18       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.